Skip to main content
padlock icon - secure page this page is secure

Celecoxib‐Induced Change in Atrial Electrophysiologic Substrate in Arthritis Patients

Buy Article:

$52.00 + tax (Refund Policy)

Cyclooxygenase‐2 inhibitors, the newest class of nonsteroidal antiinflammatories, pose an increased risk of adverse cardiovascular events, in particular atrial fibrillation (AF). We hypothesized that the COX‐2 inhibitor celecoxib alters atrial electrophysiology, and thus promotes the development of AF.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: P‐wave duration; atrial fibrillation; inflammatory arthritis

Document Type: Research Article

Publication date: January 1, 2014

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more